Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Advanced Cell Diagnostics management update

    Advanced Cell Diagnostics Inc., Hayward, Calif. Business: Diagnostic Hired: Tom Olenic as chief commercial officer, formerly general manager of the sequencing organization and SVP of commercial operations of the …

    Published on 12/15/2014
  • Apricus Biosciences management update

    Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Business: Drug delivery, Genitourinary, Cancer Hired: Brian Dorsey as chief development officer, a newly created position, formerly SVP of pharmaceutical …

    Published on 12/15/2014
  • Asceneuron board of directors update

    Asceneuron S.A., Geneva, Switzerland Business: Neurology Appointed: Raymond Hill, formerly executive director of European licensing and external research at Merck & Co. Inc.

    Published on 12/15/2014
  • Bellicum management update

    Bellicum Pharmaceuticals Inc., Houston, Texas Business: Cancer Hired: Peter Hoang as SVP of business development and strategy, formerly headed the new venture formation and development effort at University of Texas MD …

    Published on 12/15/2014
  • FlowMetric management update

    FlowMetric Inc., Doylestown, Pa. Business: Supply/Service, Diagnostic Hired: Amy Williams as president and a director of FlowMetrics affiliate company, FlowMetric Diagnostics Inc., effective Sept. 1, formerly president …

    Published on 12/15/2014
  • Foundation Medicine management update

    Foundation Medicine Inc. (NASDAQ:FMI), Cambridge, Mass. Business: Diagnostic, Pharmacogenetics Hired: David Daly as chief commercial officer, formerly VP of commercial operations in the anatomic pathology division at …

    Published on 12/15/2014
  • Innocoll management update

    Innocoll GmbH (NASDAQ:INNL), Athlone, Ireland Business: Drug delivery, Neurology, Infectious Hired: Tony Zook as CEO, formerly EVP of global commercial operations at AstraZeneca plc; he succeeds Michael Myers, who …

    Published on 12/15/2014
  • Lannett management update

    Lannett Co. Inc. (NYSE:LCI), Philadelphia, Pa. Business: Generics Hired: Michael Bogda as president, formerly EVP of Americas technical operations at Teva Pharmaceutical Industries Ltd.; he succeeds Arthur Bedrosian, …

    Published on 12/15/2014
  • Merck management update

    Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Transitioned: Jacques Cholat, VP of global vaccines marketing and commercial operations, to interim president of Merck Vaccines; and Julie …

    Published on 12/15/2014
  • Neogen management update

    Neogen Corp. (NASDAQ:NEOG), Lansing, Mich. Business: Diagnostic, Veterinary Hired: Richard Calk as president and COO, formerly VP of chemicals at Nexeo Solutions LLC; he succeeds Steve Snyder

    Published on 12/15/2014
  • NinePoint management update

    NinePoint Medical Inc., Cambridge, Mass. Business: Diagnostic Hired: Christopher von Jako as president and CEO, formerly president and CEO of NeuroTherm Inc.

    Published on 12/15/2014
  • Ocera management update

    Ocera Therapeutics Inc. (NASDAQ:OCRX), Palo Alto, Calif. Business: Gastrointestinal, Hepatic, Neurology Promoted: Michael Byrnes to CFO from VP of finance; he succeeds acting CFO Sharon Tetlow

    Published on 12/15/2014
  • ONL Therapeutics management update

    ONL Therapeutics LLC, Ann Arbor, Mich. Business: Ophthalmic Hired: Linda Johnson as SVP of operations, formerly executive director of worldwide development at Pfizer Inc. Transitioned: David Zacks to CSO from president…

    Published on 12/15/2014
  • Osiris management update

    Osiris Therapeutics Inc. (NASDAQ:OSIR), Columbia, Md. Business: Cancer, Cardiovascular, Musculoskeletal Hired: Jon Hopper as CMO, formerly VP and global medical director at Stryker Corp.

    Published on 12/15/2014
  • Paratek management update

    Paratek Pharmaceuticals Inc. (NASDAQ:PRTK), Boston, Mass. Business: Infectious Hired: Douglas Pagan as CFO, effective Dec. 18, formerly VP of finance at Acceleron Pharma Inc.; he succeeds interim CFO Kathryn Boxmeyer

    Published on 12/15/2014
  • Prenetics management update

    Prenetics Inc., Hong Kong, China Business: Diagnostic Hired: Danny Yeung as CEO, formerly CEO of Groupon Inc.s Groupon East Asia unit

    Published on 12/15/2014
  • Pronutria management update

    Pronutria Inc., Cambridge, Mass. Business: Musculoskeletal, Endocrine/Metabolic, Nutraceuticals Hired: Peter Mueller as president of R&D and CSO, formerly EVP of global R&D and CSO of Vertex Pharmaceuticals Inc.

    Published on 12/15/2014
  • Relmada management update

    Relmada Therapeutics Inc. (OTCBB:RLMD), New York, N.Y. Business: Neurology Hired: Michael Becker as SVP of finance and corporate development, formerly president of MDB Communications LLC

    Published on 12/15/2014
  • Roche management update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Pharmaceuticals Retiring: Richard Scheller as head of research and early development at Roches Genentech Inc. unit, effective Dec. 31; he will be succeeded by …

    Published on 12/15/2014
  • Soligenix management update

    Soligenix Inc. (OTCBB:SNGX), Princeton, N.J. Business: Transplant, Gastrointestinal, Cancer Transitioned: Oreola Donini to SVP and CSO from VP of clinical R&D; she succeeds Robert Brey

    Published on 12/15/2014
  • Synta management update

    Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Hired: Marc Schneebaum as SVP and CFO, formerly president, CEO and a director of now defunct Predictive BioSciences Inc.; …

    Published on 12/15/2014
  • Tal Medical management update

    Tal Medical Inc., Boston, Mass. Business: Neurology Hired: Atul Pande as EVP and CMO, formerly SVP and senior advisor of pharmaceutical R&D at GlaxoSmithKline plc

    Published on 12/15/2014
  • Affymax management update

    Affymax Inc. (OTCQB:AFFY), Cupertino, Calif. Business: Hematology Hired: Jonathan Couchman as president, CEO and a director, formerly CEO, CFO and chairman of Myrexis Inc.

    Published on 12/8/2014
  • Agilis Biotherapeutics management update

    Agilis Biotherapeutics LLC, Germantown, Md. Business: Neurology, Gene/Cell therapy Hired: Greg Robinson as CSO, formerly senior director of rare diseases business development at Shire plc

    Published on 12/8/2014
  • Allena Pharmaceuticals board of directors update

    Allena Pharmaceuticals Inc., Newton, Mass. Business: Endocrine/Metabolic Appointed: Axel Bolte, investment advisor at HBM Partners

    Published on 12/8/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993